High Potency APIs (HPAPIs) Market Research Report 2023-2030: CMO Expansion Driving Growth
The “High Potency APIs (HPAPIs) – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offerings. The global HPAPIs market was valued at $26.3 billion in 2023 and is projected…
bioAffinity Technologies Prices $2.66 Million Direct Offering and Private Placement
bioAffinity Technologies Announces $2.66 Million Offering with Concurrent Private Placement bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology firm dedicated to noninvasive cancer detection, has entered into a securities purchase…
COPD Drug Market Analysis & Forecasts 2024-2033: High Unmet Needs & Late-Stage Therapies
New Report: COPD Drug Market Analysis and Forecast (2024-2033) ResearchAndMarkets.com has released the report “COPD: Seven-Market Drug Forecast and Market Analysis,” detailing the COPD drug market across seven major regions:…
Biological Lattice Industries Secures $1.8 Million Pre-Seed Funding from Uni.Fund to Democratize Biofabrication
Biological Lattice Industries Secures $1.8 Million Pre-Seed Funding to Democratize Biofabrication Biological Lattice Industries Corp. (BLI), an innovator in biofabrication and life sciences research and development, has successfully closed a…
32% of Life Science Marketing Teams Lack KPI Awareness for Customer Engagement Investments
Trinity Life Sciences Launches New Omnichannel Reporting Suite for Enhanced Marketing Insights Trinity Life Sciences, a leader in strategy, insights, and analytics for the life sciences sector, has unveiled an…
Ferring Pharmaceuticals Showcases Commitment to Fertility Care at 2024 ASRM Congress
Ferring Pharmaceuticals Showcases Commitment to Advancing Fertility Care at 2024 ASRM Congress Ferring Pharmaceuticals will present new data from four abstracts at the 2024 American Society for Reproductive Medicine (ASRM)…
Actineer, the Joint Venture of ITM and CNL, Launches Actinium-225 Production
Successful Cyclotron Irradiation of Ra-226 Paves the Way for Actineer’s Large-Scale Ac-225 Production for Cancer Treatments Actineer, the joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., has achieved…
KalVista Pharmaceuticals to Showcase Data at 2024 ACAAI Annual Scientific Meeting
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced that five of its abstracts have been accepted for e-Poster presentations at the 2024 Annual Scientific Meeting of the American College of Allergy,…
Nordic Group BV Expands U.S. Launch of LACRIFILL® Gel for Dry Eye Treatment
Nordic Pharma, a subsidiary of Nordic Group BV, is advancing the U.S. introduction of LACRIFILL® Canalicular Gel, a novel therapy for dry eye, during the 2024 American Academy of Ophthalmology…
Celltrion Highlights Two-Year Analysis Supporting Dose Escalation for CT-P13 SC in IBD
Celltrion has announced two-year findings from a post-hoc analysis of the LIBERTY studies (LIBERTY-CD and LIBERTY-UC), presented at United European Gastroenterology (UEG) Week 2024 in Vienna. The analysis shows that…
Merck’s Clesrovimab Significantly Reduces RSV Incidence and Hospitalizations in Infants
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has shared positive results from its Phase 2b/3 clinical trial (MK-1654-004) evaluating clesrovimab, an investigational monoclonal antibody designed to…
Medidata Launches Rave Lite to Accelerate Early and Late-Stage Clinical Trial Growth
Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has launched Medidata Rave Lite, an extension of its flagship clinical research software,…